Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
An approachable overview comparing passive retirement investing using index funds versus ETFs, highlighting costs, flexibility, and long-term potential.
25,613 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Southeast Asia’s fast-growing hospitality is expanding rapidly, but a persistent labor shortage threatens growth as b...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
MercadoLibre fell in February amid margin concerns and tougher competition in LATAM. This article breaks down the for...
Midwest apartment markets are turning brighter as rents rise and debt costs ease. BAM Capital now offers accredited i...
Tensions near the Strait of Hormuz are sparking ripples across energy markets and corporate budgets. This crisis is f...
Xcel Brands faces a pivotal year in 2025 as it leans on licensed partnerships and cost discipline. This guide outline...
Gaotu's Q1 2026 earnings reveal clues about growth, profitability, and execution in a competitive online education ma...
A six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
AI-enabled search is changing how buyers find real estate services. The real estate playbook getting rewritten means ...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...